bendamustine hydrochloride has been researched along with Infusion Site Adverse Event in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anthony, SP; Chanas, B; Cheung, EM; Edenfield, WJ; Hepner, A; Mattar, B; Mutch, PJ; Smith, M | 1 |
1 trial(s) available for bendamustine hydrochloride and Infusion Site Adverse Event
| Article | Year |
|---|---|
Safety and Pharmacokinetics of Bendamustine Rapid-Infusion Formulation.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Bendamustine Hydrochloride; Biological Availability; Chemistry, Pharmaceutical; Cross-Over Studies; Female; Humans; Injection Site Reaction; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Therapeutic Equivalency | 2017 |